COYA 302
C302-CLN-2301
Phase 2 small_molecule active
Quick answer
COYA 302 for Amyotrophic Lateral Sclerosis (ALS) is a Phase 2 program (small_molecule) at Coya Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coya Therapeutics
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active